상세 보기
Analysis of Asian patients (pts) with HR+/HER2-early breast cancer (EBC) treated with ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI): 5-year outcomes from NATALEE
- Lu, Y-S.;
- Stroyakovskiy, D. L.;
- Sohn, J.;
- Park, Y. H.;
- Huang, C-s.;
- 외 13명
Citations
WEB OF SCIENCE
0- 제목
- Analysis of Asian patients (pts) with HR+/HER2-early breast cancer (EBC) treated with ribociclib (RIB) plus nonsteroidal aromatase inhibitor (NSAI): 5-year outcomes from NATALEE
- 저자
- Lu, Y-S.; Stroyakovskiy, D. L.; Sohn, J.; Park, Y. H.; Huang, C-s.; Im, S-a.; Jung, K. H.; Chan, A.; Zhang, J.; Lee, J.; Kim, J. H.; Chung, C-f.; Slamon, D.; Sakalosh, V.; Gao, M.; Amin, K.; Harun, N.; Xu, B.
- 발행일
- 2025-12
- 유형
- Meeting Abstract
- 권
- 36